openPR Logo
Press release

Deadline on Oct. 14th coming up in Lawsuit filed for certain Investors in CVS Health Corporation (NYSE: CVS)

10-14-2019 10:29 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on October 14, 2019 in the lawsuit for certain investors in CVS Health Corporation (NYSE: CVS).

A Deadline is coming up on October 14, 2019 in the lawsuit for certain investors in CVS Health Corporation (NYSE: CVS).

A deadline is coming up on October 14, 2019 in the lawsuit filed for certain investors of CVS Health Corporation (NYSE: CVS) over alleged securities laws violations by CVS Health Corporation.

Investors who purchased shares of CVS Health Corporation (NYSE: CVS) have certain options and there are strict and short deadlines running. Deadline: October 14, 2019. NYSE: CVS stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the District of Rhode Island the plaintiff alleges that Aetna shareholders approved the Acquisition not knowing that CVS’s reporting of its goodwill asset was not GAAP-compliant, that the Omnicare-related goodwill was materially impaired, and that the price of CVS Health Corporation shares was materially inflated.

Furthermore, the plaintiff alleges that the Offering Documents that were filed in connection with CVS’s acquisition of Aetna on November 28, 2018 contained materially false and/or misleading statements about CVS Health Corporation’s compliance with Generally Accepted Accounting Principles (“GAAP”). In particular, the plaintiff claims that CVS Health Corporation falsely represented in the Offering Documents that it had properly accounted for its $6+ billion goodwill asset, as reported in the “LTC unit,” associated with CVS’s 2015 acquisition of LTC pharmacies of Omnicare.

Those who purchased shares of CVS Health Corporation (NYSE: CVS) have certain options and should contact the Shareholders Foundation.
About Shareholders Foundation, Inc.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on Oct. 14th coming up in Lawsuit filed for certain Investors in CVS Health Corporation (NYSE: CVS) here

News-ID: 1848612 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for CVS

Pharmacy Benefit Management (PBM) Market to Eyewitness Stunning Growth by 2027 C …
Information about market environment and consumer buying patterns provided in the Pharmacy Benefit Management (PBM) market survey report is of great help for key players to bring new product into the market. Some prominent factors including marketing channels, metrics and demographics along with economic crisis caused due to the COVID-19 and huge losses obtained by the business sectors across the world are also covered. It provides in-detail insights into
Pharmacy Benefit Management (PBM) Market Set For Next Leg Of Growth | CVS Health …
The ‘ Pharmacy Benefit Management (PBM) market’ research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market overview, Pharmacy Benefit Management (PBM)market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Pharmacy Benefit Management
Lawsuit filed for Investors in formerly Aetna who received shares of CVS Health …
An investor, who purchased shares of CVS Health Corporation (NYSE: CVS), filed a lawsuit over alleged violations of Federal Securities Laws by CVS Health Corporation in connection with CVS’s acquisition of Aetna on November 28, 2018. Investors who acquired shares of CVS Health Corporation (NYSE: CVS) in connection with CVS’s acquisition of Aetna on November 28, 2018, you have certain options and for certain investors are short and strict deadlines running.
Global Pharmacy Benefit Management (PBM) Sales Market Report 2018 : CVS Health ( …
Researchmoz added Most up-to-date research on "Global Pharmacy Benefit Management (PBM) Sales Market Report 2018" to its huge collection of research reports. This report studies the global Pharmacy Benefit Management (PBM) market status and forecast, categorizes the global Pharmacy Benefit Management (PBM) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and
Global Pharmacy Benefit Management (PBM) Market Report 2025: CVS Health (CVS),Ex …
Qyresearchreports include new market research report "Global Pharmacy Benefit Management (PBM) Market Research Report 2018" to its huge collection of research reports. The growth progression of the global Pharmacy Benefit Management (PBM) market is molded by an assorted scope of provincial and global factors and trends, the definite record of which shapes the center of the report. The examination introduces inside and out bits of knowledge into different improvements, recognizes wide
Pharmacy Benefit Management (PBM) Market Future Scope Including Top Players CVS …
HTF MI recently introduced Global Pharmacy Benefit Management (PBM) Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are CVS Health (CVS), Express Scripts, OptumRx (UnitedHealth), Humana Pharmacy